Mark D. Hoffman

18 papers receiving 332 citations

Peers

Mark D. Hoffman
Comparison fields: 5 of 73
  • Otorhinolaryngology 71
  • Dermatology 60
  • Periodontics 24
  • Sensory Systems 24
  • Immunology 81
Replace Makoto Kurose with:
Makoto Kurose Japan
J Traserra Spain
Tomasz M. Basinski Switzerland
Jia‐Zeng Su China
Sheen‐Yie Fang Taiwan
Lydia Hou United States
Tijjani Umar United Kingdom
Shuqiong Wen China
Xuejun You China
Ping‐Ping Cao China
Mark D. Hoffman relative to Makoto Kurose Japan Makoto Kurose's profile →
Citations per field
00.5×1.5×1.8×
Makoto Kurose · 1×
Citations per year

Countries citing papers authored by Mark D. Hoffman

Since Specialization
Citations

This map shows the geographic impact of Mark D. Hoffman's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mark D. Hoffman with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mark D. Hoffman more than expected).

Fields of papers citing papers by Mark D. Hoffman

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mark D. Hoffman. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mark D. Hoffman. The network helps show where Mark D. Hoffman may publish in the future.

Co-authors

The 24 scholars most cited alongside Mark D. Hoffman, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Mark D. Hoffman Line = papers co-authored together Mark D. Hoffman links everyone, so they are left out of the graph.

All Works

18 of 18 papers shown
#Work
1 2008132
2 201161
3 201139
4 202319
5 200116
6 201314
7 199512
8 19929
9
Dapsone in the treatment of persistent erythema multiforme.
20069
10 20078
11 20186
12 20075
13 20055
14 20222
15 20202
16 19972
17 20211
18 20011

About Mark D. Hoffman

Mark D. Hoffman is a scholar working on Dermatology, Rheumatology, Epidemiology, Pathology and Forensic Medicine and Immunology, having authored 18 papers that have together received 343 indexed citations. Recurring topics across this work include Autoimmune and Inflammatory Disorders (8 papers), Skin Diseases and Diabetes (5 papers), Autoimmune Bullous Skin Diseases (5 papers), Eosinophilic Disorders and Syndromes (4 papers), Immunodeficiency and Autoimmune Disorders (2 papers), Inflammatory Myopathies and Dermatomyositis (2 papers), Dermatological and COVID-19 studies (2 papers) and Inflammasome and immune disorders (2 papers). The work is most often cited by research in Otorhinolaryngology (71 citations), Dermatology (60 citations), Periodontics (24 citations), Sensory Systems (24 citations) and Immunology (81 citations). Mark D. Hoffman has collaborated with scholars based in United States. Frequent co-authors include Minkyo Jung, Diego Preciado, Tina C. Huang, Frank G. Ondrey, Jizhen Lin, Steven K. Juhn, Timothy T. K. Jung, Andrew B. Nesterovitch, Tibor T. Glant and Michael D. Tharp. Their work appears in journals such as Journal of the American Academy of Dermatology, American Journal Of Pathology, Dermatologic Therapy, Clinical and Experimental Otorhinolaryngology and Clinics in Dermatology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026